LPCN 1021: Clinical Trials

3 trials of LPCN 1021, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3

Follow LPCN 1021: new trials by email Literature Review of LPCN 1021 trials Research Report on LPCN 1021

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
LPCN 1021 - Hypogonadism, Male
Phase 3CompletedLipocine Inc.1382018-04-302021-06-10
Dosing Flexibility Study of Oral Testosterone Undecanoate (TU, LPCN 1021)
LPCN 1021 - Hypogonadism, Male
Phase 3CompletedLipocine Inc.1002017-01-012019-10-23
Dosing Validation Study of Oral Testosterone Undecanoate (TU, LPCN 1021).
LPCN 1021 - Hypogonadism, Male
Phase 3CompletedLipocine Inc.952016-12-012019-10-23

Conditions studied

Eunuchism (3)

Sponsors

Lipocine Inc. (3)

Countries

United States (1)

Top investigators

Anthony DelConte, MD (2)  ·  Anthony Delconte, MD (1)

Results publications

PMID 34191621, PMID 34994093